Recalls and Safety Alerts: Warning on Combining Triptans and SSRIs/SNRIs
Published by Food and Drug Adminstration (FDA): Patient Safety September 30th, 2006 in Patient Safety, Regulatory AffairsFDA has alerted healthcare professionals about a possible life-threatening condition that can occur when triptans (e.g., Imitrex) are taken concomitantly with SSRIs (e.g., Paxil and Prozac) or SNRIs (e.g., Cymbalta)
All of these drug increase ser…